ERBB2 and breast cancer: Among the BC subtypes, “pure” HER2-positive tumors (defined by IHC classification as a HER2 score of 3+ or 2+ with ERBB2 amplification by ISH)6,7 account for approximately 15–20% of all cases8 and exhibit more aggressive behavior than HER2-negative tumors5.